The Veteran's bone cancer claim is denied because there is no current disability. Service connection for myeloma with myelodysplastic syndrome (claimed as leukemia) has been granted.
The deciding factor: There is no current diagnosis of bone cancer, and the Veteran's service-connected multiple myeloma does not meet the criteria for presumptive service connection due to herbicide exposure.
- Claimed conditions
- bone cancer, myeloma with myelodysplastic syndrome
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- March 25, 2026
- Citation
- A26027178
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation A26027178.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Granted
The Veteran's claim for service connection for prostate cancer, bone cancer, and lymph node cancer has been granted. The prostate cancer is presumed due to herbicide agent exposure during service at RTAFB Takhli. Bone cancer is secondary to the service-connected prostate cancer. Lymph node cancer is also considered secondary to prostate cancer.
- Whole decision: Remanded (sent back)
The Board has remanded the cases of prostate cancer and bone cancer for further review due to inadequate medical opinions regarding service connection.
- Whole decision: Remanded (sent back)
The Board has remanded the appellant's claims for accrued benefits due to insufficient evidence regarding the relationship between the Veteran's cancers and his service-connected disabilities, specifically gastritis with hyperacidity and coronary artery disease. The VA is required to obtain medical opinions on the nature and etiology of the Veteran's right kidney cancer, stomach cancer, and bone cancer.
- Whole decision: Denied
The Veteran's appeal for a higher rating for prostate cancer and an earlier effective date for loss of use of the right foot has been denied. The Veteran is already receiving the maximum schedular rating for prostate cancer, which was granted in December 2023. The effective date for service connection for loss of use of the right foot was set at January 22, 2023.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.